Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

Annals of Neurology

Volumn 47, Issue 4, 2000, Pages 462-469

  Kidwell, Chelsea S ^a,b   Saver, Jeffrey L ^a,b   Mattiello, James ^b   Starkman, Sidney ^a,b   Vinuela, Fernando ^a,b   Duckwiler, Gary ^a,b   Gobin, Y Pierre ^a,b   Jahan, Reza ^a,b   Vespa, Paul ^a,b   Kalafut, Mary ^a,b   Alger, Jeffry R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPERFUSION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0034117736     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.0.CO;2-Y     Document Type: Article

References (43)

1. NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
2. Furlan AJ, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-2011
3. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22
4. O'Connor RE, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 1999;33:9-14
5. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis - not a panacea for ischemic stroke. N Engl J Med 1997;337:1309-1310
6. Fisher M. Characterizing the target of acute stroke therapy. Stroke 1997;28:866-872
7. Koroshetz WJ, Gonzalez G. Diffusion-weighted MRI: an ECG for "brain attack"? Ann Neurol 1997;41:565-566
8. Warach S, Gaa J, Siewert B, et al. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231-241
9. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609
10. Lutsep HL, Albers GW, DeCrespigny A, et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580
11. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR 1990;11:423-429
12. Schlaug G, Siewert B, Benfield A, et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113-119
13. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41: 581-589
14. Albers GW, Lansberg MG, O'Brien MW, et al. Evolution of cerebral infarct volume assessed by diffusion-weighted MRI: implication for clinical stroke trials. Neurology 1999;52:A453 (Abstract)
15. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426
16. Tong DC, Yenari MA, Albers GW, et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998;50:864-870
17. Fisher M, Garcia JH. Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888
18. Dijkhuizen RM, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K. Regional assessment of tissue oxygenation and the temporal evolution of hemodynamic parameters and water diffusion during acute focal ischemia in rat brain. Brain Res 1997;750:161-170
19. Mintorovitch J, Moseley ME, Chileuitt L, et al. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 1991; 18:39-50
20. Hossmann KA, Fischer M, Bockhorst K, Hoehn-Berlage M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J Cereb Blood Flow Metab 1994;14: 723-731
21. Hasegawa Y, Fisher M, Latour LL, et al. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology 1994;44:1484-1490
22. Minematsu K, Li L, Sotak CH, et al. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992;23:1304-1310
23. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605
24. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725
25. Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736
26. 2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18: 935-940
27. Pierpaoli C, Alger JR, Righini A, et al. High temporal resolution diffusion MRI of global cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 1996;16:892-905
28. TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings: TIMI study group. N Engl J Med 1985;312:932-936
29. Kidwell CS, Alger JR, Di Salle F, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30:1174-1180
30. Marks MP, de Crespigny A, Lentz D, et al. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996;199:403-408
31. Jansen O, Schellinger P, Fiebach J, et al. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999;353:2036-2037 (Letter)
32. Marks MP, Tong DC, Beaulieu C, et al. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999;52:1792-1798
33. Li F, Han SS, Tatlisumak T, et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 1999;46:333-342
34. Dijkhuizen RM, Knollema S, van der Worp HB, et al. Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: evidence for region-specific sensitivity and delayed damage. Stroke 1998;29:695-704
35. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol 1990;47:1245-1254
36. Rordorf G, Koroshetz WJ, Copen WA, et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-943
37. Saver JL, Johnston KC, Homer D, et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke 1999;30:293-298
38. Brass LM. Trial design issues: endpoints and sample size. Cerebrovasc Dis 1995;5:3-11
39. Temple RJ. A regulatory authority's opinion about surrogate endpoints. In: Nimmo WS, Tucker GT, eds. Clinical measurement in drug evaluation. New York: John Wiley, 1995
40. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8:431-440
41. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59
42. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42: 164-170
43. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426